-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9

Benzinga·11/04/2026 23:12:34
Listen to the news
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $10 to $9.